More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis

• Príomhchruthaitheoirí: Andrew Blauvelt (Údar), Kilian Eyerich (Údar), Alan D. Irvine (Údar), Marjolein de Bruin-Weller (Údar), Shawn G. Kwatra (Údar), Melinda Gooderham (Údar), Brian Kim (Údar), Brian M. Calimlim (Údar), Wan-Ju Lee (Údar), Eliza M. Raymundo (Údar), Yingyi Liu (Údar), Sarah Ofori (Údar), Andrew M. Platt (Údar), Jonathan I. Silverberg (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Adis, Springer Healthcare, 2024-08-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Abstract Introduction Atopic dermatitis (AD), with its hallmark symptoms of pruritus and skin lesions, often impairs patients' quality of life. We assessed time spent with clear/almost clear skin and no/minimal itch during upadacitinib treatment versus placebo or dupilumab among patients with m...